Pharmaceutical Executive | Manager | Commercial Access Director | Business Strategy Leader
Dubai
Summary
36+ years of experience in pharmaceutical sales, market access, and business strategy across the Middle East, Türkiye, and Africa (META) region.
Proven track record of driving revenue growth (e.g., 288.89% growth at Acino Swiss) and optimizing market share across diverse portfolios.
Expertise in market access, pricing strategies, tender management, and government affairs for international pharmaceutical companies.
Strong leadership and team development skills, with a history of building high-performing teams and fostering a winning organizational culture.
Skilled in P&L management, financial reporting, and business transformation, with a focus on operational excellence and sustainable growth.
Dual Canadian/Egyptian citizenship and 10 years UAE Golden Visa holder.
Overview
27
27
years of professional experience
2
2
Languages
Work History
General Manager
Alfa HC Group MEA
01.2024 - 12.2024
Lead the company’s transformation, growth, and operational excellence initiatives.
Spearheaded the company's developmental programs to cultivate a high-performance, winning culture.
Oversaw a diversified portfolio generating USD 225M in top-line sales.
Commercial Access Director META | Country Manager (8 Non-Direct Markets) | Director Tender META | Director Governmental & Public Affairs META | UAE Scientific Office Manager
Acino Swiss
01.2019 - 12.2023
Achieved 288.89% revenue growth, increasing annual revenue from $90M to $220M in 4 years.
Grew tender business in KSA, GEM markets, Egypt, and Iraq from $5M to $25M (200% growth) in 3 years.
Optimized cluster structures and resource allocation to align with regional priorities, supported by HR and policy guidance.
Strengthened distributor relationships, ensuring forecast accuracy and timely order fulfillment in collaboration with supply chain and finance teams.
Developed pre-launch sales plans for new products, aligning with Acino’s marketing strategy.
Established strategic partnerships, including collaboration with the Sheikh Hamdan Bin Rashid Al-Maktoum Award for Medical Sciences, to enhance healthcare services and research across the META region.
Advocated for local manufacturing initiatives in the UAE and KSA, driving compliance and accountability for non-direct markets (NDMs) with double-digit growth to $5M top-line revenue.
Enhanced market access capabilities, driving growth through high-quality products and premium pricing strategies across META.
Head of Market Access, Pricing, Public & Government Affairs | Market Access Manager Gulf | Oncology Business Manager | Senior Institution & MOH Business Supervisor
Bristol Myers-Squibb (BMS)
05.1998 - 12.2018
Successfully launched 5+ blockbuster products in immuno-oncology, virology, and immunology, generating $100M in revenue.
Implemented global pricing systems (PAS and APEX) in collaboration with worldwide pricing teams.
Spearheaded the introduction of Health Economics & Outcome Research (HEOR) in the Middle East, shaping value-based procurement strategies with McMaster University and the University of Washington.
Managed alliances with AstraZeneca and Pfizer, leading the launch of Onglyza and Apixaban in the Middle East.
Served as interim intercontinental pricing and field access manager at BMS US HQ, shaping GTM strategies for Apixaban with Pfizer’s HQ team.
Led a team of 6 market access managers and tender/communication specialists, driving double-digit revenue growth from $4M to $8M in MOH tender and institutional business.
Launched 10+ public awareness campaigns for oncology, virology, and rheumatology, focusing on prevention and education.
Commercial Manager (Middle East/Asia Pacific)
Health Care International (HCI)
05.1998 - 12.2018
Oversaw commercial operations and strategic initiatives across the Middle East and Asia Pacific regions.
Education
Leadership Diploma - Health Economics & Health Assessment Technology Program, Pharmaceutical Outcome and Research Policy Program
University of Washington
03.2013 - 10 2013
Diploma in Health Management and Social Care Services - undefined
The American University in Cairo
04.2003 - 3 2004
Bachelor of Science - Pharmacy & Pharmaceutical Science
Delivered 288.89% revenue growth at Acino Swiss, increasing annual revenue from $90M to $220M.
Grew tender business by 200%, from $5M to $25M, in 3 years.
Launched 5+ blockbuster products at BMS, generating $100M in revenue.
Introduced HEOR concepts in the Middle East, shifting procurement strategies to value-based models.
Spearheaded public awareness campaigns for oncology, virology, and rheumatology, impacting healthcare education across the region.
Personal Information
Canadian
Egyptian
Visa Status: UAE Golden Visa holder
Timeline
General Manager
Alfa HC Group MEA
01.2024 - 12.2024
Commercial Access Director META | Country Manager (8 Non-Direct Markets) | Director Tender META | Director Governmental & Public Affairs META | UAE Scientific Office Manager
Acino Swiss
01.2019 - 12.2023
Leadership Diploma - Health Economics & Health Assessment Technology Program, Pharmaceutical Outcome and Research Policy Program
University of Washington
03.2013 - 10 2013
Diploma in Health Management and Social Care Services - undefined
The American University in Cairo
04.2003 - 3 2004
Head of Market Access, Pricing, Public & Government Affairs | Market Access Manager Gulf | Oncology Business Manager | Senior Institution & MOH Business Supervisor
Bristol Myers-Squibb (BMS)
05.1998 - 12.2018
Commercial Manager (Middle East/Asia Pacific)
Health Care International (HCI)
05.1998 - 12.2018
Bachelor of Science - Pharmacy & Pharmaceutical Science